Bridging Diagnostics: Evaluating the NG-CARBA-5 Test and PCR Among Carbapenem-resistant Enterobacterales Isolated from a Multidisciplinary Hospital in Malaysia
Main Article Content
Abstract
Background: Carbapenem-resistant Enterobacterales (CRE) pose a major health threat worldwide because of limited treatment options and high mortality rates. This study investigated the detection of CRE in a multidisciplinary hospital by comparing the multiplex polymerase chain reaction (PCR) with the rapid NG-CARBA-5 assay.
Methods: A total of 58 bacterial isolates, previously recovered from various clinical specimens, were tested. Genotypic identification was performed using a multiplex PCR assay targeting carbapenemases, including blaKPC, blaNDM, and blaOXA-48. The rapid assay was conducted using the NG-CARBA-5 test kit to detect blaNDM, blaIMP, blaVIM, blaOXA-48, and blaKPC.
Results: Out of the 58 isolates tested, 36 were identified as carbapenemase producers with the rapid assay, whereas 39 were detected by PCR. All 36 carbapenemase-positive isolates detected by the rapid assay harboured the blaNDM gene, while multiplex PCR detected 19 isolates with multigenes (18 blaNDM+blaKPC and 1 blaNDM+blaOXA) and 20 isolates with single genes (18 blaNDM, 1 blaOXA, and 1 blaKPC). Discrepancies were observed among the detection methods, with four isolates reported as false negatives (FNs). This indicates a possible risk of missing colonised or infected patients, which is important in settings such as intensive care units (ICUs) or outbreaks.
Conclusion: The NG-CARBA-5 test is suitable for rapid initial screening, particularly when complemented by another phenotypic test such as the modified carbapenem inactivation method (mCIM) test.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Rabaan AA, Eljaaly K, Alhumaid S, Albayat H, Al-Adsani W, Sabour AA, et al. An overview on phenotypic and genotypic characterisation of carbapenem-resistant Enterobacterales. Medicina. 2022;58(11):1675. https://doi.org/10.3390/medicina58111675
Centers for Disease Control and Prevention (CDC). Carbapenem-resistant Enterobacteriaceae (CRE) [Internet]. Atlanta, GA: CDC; 2024 [Retrieved 2024 Feb 4]. Available at: https://www.cdc.gov/cre/about/index.html
Ma J, Song X, Li M, Yu Z, Cheng W, Yu Z, et al. Global spread of carbapenem-resistant Enterobacteriaceae: epidemiological features, resistance mechanisms, detection and therapy. Microbiol Res. 2023;266:127249. https://doi.org/10.1016/j.micres.2022.127249
Ngoo SKMH, Sakudat K, Ab Yamid S, Hashim R. The carbapenemase producing carbapenem-resistant Enterobacteriaceae (CP-CRE) gene distribution in Malaysia (2016-2021): report. Int J Infect Dis. 2023;130(Suppl 2):S133. https://doi.org/10.1016/j.ijid.2023.04.329
Bhatt P, Tandel K, Das NK, Grover N, Ranjan P, Rathi KR. Phenotypic detection and molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care center. J Mar Med Soc. 2022;24(Suppl 1):40–46. https://doi.org/10.4103/jmms.jmms_163_20
Ravikant, Kumari P, Kumar M, Roy P, Jeya M. Detection of carbapenem-resistant Enterobacteriaceae by real-time PCR and assessment of hospitalization related risk factors associated with their fecal carriage: a case-control study. J Pure Appl Microbiol. 2022;16(2):1111–1121. https://doi.org/10.22207/JPAM.16.2.37
Caliskan-Aydogan O, Alocilja EC. A review of carbapenem resistance in Enterobacterales and its detection techniques. Microorganisms. 2023;11(6):1491. https://doi.org/10.3390/microorganisms11061491
Aurilio C, Sansone P, Barbarisi M, Pota V, Giaccari LG, Coppolino F, et al. Mechanisms of action of carbapenem resistance. Antibiotics. 2022;11(3):421. https://doi.org/10.3390/antibiotics11030421
Tilahun M, Kassa Y, Gedefie A, Ashagire M. Emerging carbapenem-resistant Enterobacteriaceae infection, its epidemiology and novel treatment options: a review. Infect Drug Resist. 2021;14:4363–4374. https://doi.org/10.2147/idr.s337611
Mookerjee S, Dyakova E, Davies F, Bamford K, Brannigan ET, Holmes A, et al. Evaluating serial screening cultures to detect carbapenemase-producing Enterobacteriaceae following hospital admission. J Hosp Infect. 2018;100(1):15–20. https://doi.org/10.1016/j.jhin.2018.05.024
Chen Q, Wang M, Han M, Xu L, Zhang H. Molecular basis of Klebsiella pneumoniae colonization in host. Microb Pathog. 2023;177:106026. https://doi.org/10.1016/j.micpath.2023.106026
Lynch JP, Clark NM, Zhanel GG. Escalating antimicrobial resistance among Enterobacteriaceae: focus on carbapenemases. Expert Opin Pharmacother. 2021;22(11):1455–1474. https://doi.org/10.1080/14656566.2021.1904891
Aruhomukama D, Magiidu WT, Katende G, Ebwongu RI, Bulafu D, Kasolo R, et al. Evaluation of three protocols for direct susceptibility testing for gram negative- Enterobacteriaceae from patient samples in Uganda with SMS reporting. Sci Rep. 2024;14:2730. https://doi.org/10.1038/s41598-024-53230-w
Sisay A, Kumie G, Gashaw Y, Nigatie M, Gebray HM, Reta MA. Prevalence of genes encoding carbapenem-resistance in Klebsiella pneumoniae recovered from clinical samples in Africa: systematic review and meta-analysis. BMC Infect Dis. 2025;25:556. https://doi.org/10.1186/s12879-025-10959-7
Tullayaprayouch K, Phuadraksa T, Luk-In S, Pornsuwan S, Changkhundi P, Wichit S, et al. Development of multiplex recombinase polymerase amplification for the rapid detection of five carbapenemase (blaKPC, blaNDM, blaOXA-48-like, blaIMP, and blaVIM) and 10 mcr (mcr-1 to mcr-10) genes in blood cultures. Int J Antimicrob Agents. 2025;66(4):107567. https://doi.org/10.1016/j.ijantimicag.2025.107567
Hombach M, von Gunten B, Castelberg C, Bloemberg GV. Evaluation of the Rapidec Carba NP test for detection of carbapenemases in Enterobacteriaceae. J Clin Microbiol. 2015;53(12):3828–3833. https://doi.org/10.1128/JCM.02327-15